[1]
Herrera, S.P. et al. 2018. Hypertricosis as a dermatological adverse effect associated to the use of panitumumab. Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica. 26, 3 (Nov. 2018), 194–197. DOI:https://doi.org/10.29176/2590843X.61.